About West Careers Investors Locations News & Events Store Contact Us Blog SIGN IN Products Services Challenges Support Home Investors Press Releases Investors Home Financial Events and Presentations Corporate Governance Stock Information Transfer Agent NYSE: WST (Common Stock) Current price $433.72 Net Change +0.7 Nov 24, 2021 | 04: 02 PM EST Press Releases Back Print West to Participate in Upcoming Investor Conferences EXTON, Pa., Nov. 11, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will participate in the Jefferies London Healthcare Conference taking place on November 16-18, 2021 in London, UK. Management will participate in a Fireside Chat on Tuesday, November 16, 2021 from 5:40 p.m. – 6:15 p.m. GMT. It will also participate in the Stephens Investment Conference taking place December 1-3, 2021 in Nashville, TN. Management will participate in a Fireside Chat on Friday, December 3, 2021 from 11:00 a.m. – 11:45 p.m. CST. A live audio webcast will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events. About West West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 40 billion components and devices each year. Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2020 generated over $2.15 billion in sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com. All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. SOURCE West Pharmaceutical Services, Inc. Investor Contact: Quintin Lai, Vice President, Investor Relations, +1-610-594-3318, Quintin.Lai@westpharma.com; Media Contact: Michele Polinsky, Vice President, Global Communications, +1-610-594-3054, Michele.Polinsky@westpharma.com Email Alerts You may automatically receive West Pharmaceutical Services financial information by email. To choose your options for email notification, please enter your email address below and click Submit. Annual Reports Financial report New Corporate Governance Announcement Press Release Audio Alert SEC Filing All 8-K 10-K 10-Q By checking this box you are consenting to the use of your personal data as described in our Privacy Policy. Contact Investor Relations PRODUCTS Vial Containment Solutions Prefillable Systems Self-Injection Platforms Cartridge Systems And Components Reconstitution & Transfer Systems Specialty Components Quality Enhancements SERVICES Analytical Services West Contract Manufacturing Integrated Solutions CHALLENGES Reducing Time To Market Reducing Total Cost Of Ownership Packaging Solutions For Sensitive Molecules Single Source Solution SUPPORT Coronavirus Update Knowledge Center Get A Product Recommendation Fill-Finish Support Services Quality Support Regulatory Support Contact Us Recent Press Releases West To Participate In Upcoming Investor Conferences West Announces Third-Quarter 2021 Results And Declares Fourth-Quarter 2021 Dividend West'S NovaGuard® SA Pro Safety System Recognized For Best Technologies Innovation At INTERPHEX All Press Releases Email Subscriptions Partners Legal Notices Imprint UK Tax Strategy Terms & Conditions Privacy Policy DeltaCube Terms Of Service ©2021 West Pharmaceutical Services, Inc.®All Rights Reserved. Feedback